Phycologia australica; or, A history of Australian sea weeds ... and a synopsis of all known Australian Algae ... By William Henry Harvey.

1

A history of the British marine Polyzoa / By Thomas Hincks.

2, Plates

Natural history of Victoria. Prodromus of the zoology of Victoria; or, Figures and descriptions of the living species of all classes of the Victorian indigenous animals... By Frederick McCoy...

Decade 11-15

A history of the British zoophytes. By George Johnston.

1, Text

Soldiers' dream continued : a pictorial history of Lincoln University of Missouri

Pictorial history of Lincoln University of Missouri from 1866-1980s.

Soldiers' dream : a centennial history of Lincoln University of Missouri

A Pictorial History of Lincoln University from 1866-1966.

The history of Lincoln University

The Founding of Lincoln Institute -- Period of Development -- The Administrations of Smith, Mitchell, and Clayton -- The Grand Old Man -- The Period from 1989-1898 -- The Period of the Presidents -- Lincoln Institute at the Turn of the century -- The Period of Opposition -- From Institute to University -- A New President with a new Program -- Growth Despite Opposition -- Lincoln University since 1931.

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

Identifying the immunologic and virologic consequences of discontinuing antiretroviral therapy in HIV-infected patients is of major importance in developing long-term treatment strategies for patients with HIV-1 infection. We designed a trial to characterize these parameters after interruption of highly active antiretroviral therapy (HAART) in patients who had maintained prolonged viral suppression on antiretroviral drugs. Eighteen patients with CD4+ T cell counts ≥ 350 cells/μl and viral load below the limits of detection for ≥1 year while on HAART were enrolled prospectively in a trial in which HAART was discontinued. Twelve of these patients had received prior IL-2 therapy and had low frequencies of resting, latently infected CD4 cells. Viral load relapse to >50 copies/ml occurred in all 18 patients independent of prior IL-2 treatment, beginning most commonly during weeks 2–3 after cessation of HAART. The mean relapse rate constant was 0.45 (0.20 log10 copies) day−1, which was very similar to the mean viral clearance rate constant after drug resumption of 0.35 (0.15 log10 copies) day−1 (P = 0.28). One patient experienced a relapse delay to week 7. All patients except one experienced a relapse burden to >5,000 RNA copies/ml. Ex vivo labeling with BrdUrd showed that CD4 and CD8 cell turnover increased after withdrawal of HAART and correlated with viral load whereas lymphocyte turnover decreased after reinitiation of drug treatment. Virologic relapse occurs rapidly in patients who discontinue suppressive drug therapy, even in patients with a markedly diminished pool of resting, latently infected CD4+ T cells.

Building a retrospective collection in pharmacy: a brief history of the literature with some considerations for U.S. health sciences library professionals

This paper argues that historical works in pharmacy are important tools for the clinician as well as the historian. With this as its operative premise, delineating the tripartite aspects of pharmacy as a business enterprise, a science, and a profession provides a conceptual framework for primary and secondary resource collecting. A brief history and guide to those materials most essential to a historical collection in pharmacy follows. Issues such as availability and cost are discussed and summarized in checklist form. In addition, a glossary of important terms is provided as well as a list of all the major U.S. dispensatories and their various editions. This paper is intended to serve as a resource for those interested in collecting historical materials in pharmacy and pharmaco-therapeutics as well as provide a history that gives context to these classics in the field. This should provide a rationale for selective retrospective collection development in pharmacy.